UniProt ID | EDEM3_HUMAN | |
---|---|---|
UniProt AC | Q9BZQ6 | |
Protein Name | ER degradation-enhancing alpha-mannosidase-like protein 3 | |
Gene Name | EDEM3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 932 | |
Subcellular Localization | Endoplasmic reticulum lumen . | |
Protein Description | Involved in endoplasmic reticulum-associated degradation (ERAD). Accelerates the glycoprotein ERAD by proteasomes, by catalyzing mannose trimming from Man8GlcNAc2 to Man7GlcNAc2 in the N-glycans. Seems to have alpha 1,2-mannosidase activity (By similarity).. | |
Protein Sequence | MSEAGGRGCGSPVPQRARWRLVAATAAFCLVSATSVWTAGAEPMSREEKQKLGNQVLEMFDHAYGNYMEHAYPADELMPLTCRGRVRGQEPSRGDVDDALGKFSLTLIDSLDTLVVLNKTKEFEDAVRKVLRDVNLDNDVVVSVFETNIRVLGGLLGGHSLAIMLKEKGEYMQWYNDELLQMAKQLGYKLLPAFNTTSGLPYPRINLKFGIRKPEARTGTETDTCTACAGTLILEFAALSRFTGATIFEEYARKALDFLWEKRQRSSNLVGVTINIHTGDWVRKDSGVGAGIDSYYEYLLKAYVLLGDDSFLERFNTHYDAIMRYISQPPLLLDVHIHKPMLNARTWMDALLAFFPGLQVLKGDIRPAIETHEMLYQVIKKHNFLPEAFTTDFRVHWAQHPLRPEFAESTYFLYKATGDPYYLEVGKTLIENLNKYARVPCGFAAMKDVRTGSHEDRMDSFFLAEMFKYLYLLFADKEDIIFDIEDYIFTTEAHLLPLWLSTTNQSISKKNTTSEYTELDDSNFDWTCPNTQILFPNDPLYAQSIREPLKNVVDKSCPRGIIRVEESFRSGAKPPLRARDFMATNPEHLEILKKMGVSLIHLKDGRVQLVQHAIQAASSIDAEDGLRFMQEMIELSSQQQKEQQLPPRAVQIVSHPFFGRVVLTAGPAQFGLDLSKHKETRGFVASSKPSNGCSELTNPEAVMGKIALIQRGQCMFAEKARNIQNAGAIGGIVIDDNEGSSSDTAPLFQMAGDGKDTDDIKIPMLFLFSKEGSIILDAIREYEEVEVLLSDKAKDRDPEMENEEQPSSENDSQNQSGEQISSSSQEVDLVDQESSEENSLNSHPESLSLADMDNAASISPSEQTSNPTENHETTNLNGECTDLDNQLQEQSETEEDSNPNVSWGKKVQPIDSILADWNEDIEAFEMMEKDEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
104 | Phosphorylation | DDALGKFSLTLIDSL HHHHHHHHEEHHHHC | 24.75 | 24114839 | |
106 | Phosphorylation | ALGKFSLTLIDSLDT HHHHHHEEHHHHCCE | 22.07 | 24114839 | |
118 | N-linked_Glycosylation | LDTLVVLNKTKEFED CCEEEEECCCHHHHH | 38.04 | UniProtKB CARBOHYD | |
146 | Ubiquitination | DVVVSVFETNIRVLG CEEEEEEECCCHHHH | 38.50 | - | |
165 | Ubiquitination | GHSLAIMLKEKGEYM CCEEEEEHHHCCCHH | 5.46 | - | |
189 | Ubiquitination | MAKQLGYKLLPAFNT HHHHHCCCHHHCCCC | 41.57 | - | |
195 | N-linked_Glycosylation | YKLLPAFNTTSGLPY CCHHHCCCCCCCCCC | 44.55 | 19159218 | |
208 | Ubiquitination | PYPRINLKFGIRKPE CCCEEEEEEEECCCC | 36.74 | - | |
219 | Ubiquitination | RKPEARTGTETDTCT CCCCCCCCCCCCCCH | 18.92 | - | |
262 | Ubiquitination | ALDFLWEKRQRSSNL HHHHHHHHHHCCCCC | 42.10 | - | |
266 | Phosphorylation | LWEKRQRSSNLVGVT HHHHHHCCCCCEEEE | 18.42 | 28348404 | |
267 | Phosphorylation | WEKRQRSSNLVGVTI HHHHHCCCCCEEEEE | 36.05 | 28348404 | |
273 | Phosphorylation | SSNLVGVTINIHTGD CCCCEEEEEEEECCC | 11.46 | 28348404 | |
286 | Phosphorylation | GDWVRKDSGVGAGID CCEEECCCCCCCCCH | 38.11 | - | |
295 | Phosphorylation | VGAGIDSYYEYLLKA CCCCCHHHHHHHHHH | 9.14 | - | |
296 | Phosphorylation | GAGIDSYYEYLLKAY CCCCHHHHHHHHHHH | 11.31 | - | |
303 | Phosphorylation | YEYLLKAYVLLGDDS HHHHHHHHHHHCCHH | 7.05 | 18785766 | |
310 | Phosphorylation | YVLLGDDSFLERFNT HHHHCCHHHHHHHHH | 36.15 | 18785766 | |
358 | Ubiquitination | LLAFFPGLQVLKGDI HHHHCCCCEEECCCC | 3.03 | 21890473 | |
392 | Ubiquitination | LPEAFTTDFRVHWAQ CCCCCCCCCCEECCC | 26.71 | - | |
392 | Ubiquitination | LPEAFTTDFRVHWAQ CCCCCCCCCCEECCC | 26.71 | 21890473 | |
404 | Ubiquitination | WAQHPLRPEFAESTY CCCCCCCHHHHCCCE | 49.06 | - | |
427 | Ubiquitination | PYYLEVGKTLIENLN CEEEEHHHHHHHHHH | 45.38 | - | |
435 | Ubiquitination | TLIENLNKYARVPCG HHHHHHHHHCCCCCC | 43.37 | 21890473 | |
435 | Ubiquitination | TLIENLNKYARVPCG HHHHHHHHHCCCCCC | 43.37 | 22817900 | |
447 | Ubiquitination | PCGFAAMKDVRTGSH CCCEECCCCCCCCCC | 48.63 | - | |
504 | N-linked_Glycosylation | PLWLSTTNQSISKKN HHHHHCCCCCCCCCC | 33.42 | UniProtKB CARBOHYD | |
511 | N-linked_Glycosylation | NQSISKKNTTSEYTE CCCCCCCCCCCCCEE | 52.94 | UniProtKB CARBOHYD | |
512 | Ubiquitination | QSISKKNTTSEYTEL CCCCCCCCCCCCEEC | 40.35 | - | |
550 | Ubiquitination | QSIREPLKNVVDKSC HHHHHHHHHCCCCCC | 59.41 | 29967540 | |
551 | Ubiquitination | SIREPLKNVVDKSCP HHHHHHHHCCCCCCC | 46.88 | - | |
555 | Ubiquitination | PLKNVVDKSCPRGII HHHHCCCCCCCCCEE | 42.20 | 29967540 | |
573 | Ubiquitination | ESFRSGAKPPLRARD HHHHCCCCCCCCHHH | 51.17 | 29967540 | |
594 | Ubiquitination | EHLEILKKMGVSLIH HHHHHHHHHCCEEEE | 37.12 | - | |
662 | Ubiquitination | HPFFGRVVLTAGPAQ CCCCCEEEEEECCHH | 3.66 | - | |
676 | Ubiquitination | QFGLDLSKHKETRGF HHCCCHHHCCCCCCE | 67.03 | - | |
686 | Phosphorylation | ETRGFVASSKPSNGC CCCCEECCCCCCCCC | 33.33 | 22210691 | |
690 | Phosphorylation | FVASSKPSNGCSELT EECCCCCCCCCCCCC | 49.98 | 22210691 | |
694 | Phosphorylation | SKPSNGCSELTNPEA CCCCCCCCCCCCHHH | 36.72 | 22210691 | |
705 | Ubiquitination | NPEAVMGKIALIQRG CHHHHHHHHHHHHCC | 13.50 | - | |
719 | Ubiquitination | GQCMFAEKARNIQNA CCCHHHHHHHCCCCC | 49.57 | 29967540 | |
769 | Phosphorylation | IPMLFLFSKEGSIIL CCEEEEECCCCCCHH | 31.76 | 24719451 | |
810 | N-linked_Glycosylation | EEQPSSENDSQNQSG CCCCCCCCCCCCCCC | 57.07 | UniProtKB CARBOHYD | |
814 | N-linked_Glycosylation | SSENDSQNQSGEQIS CCCCCCCCCCCCCCC | 41.77 | UniProtKB CARBOHYD | |
835 | Phosphorylation | DLVDQESSEENSLNS EECCCCCCHHHCCCC | 48.45 | 24275569 | |
900 | N-linked_Glycosylation | TEEDSNPNVSWGKKV CCCCCCCCCCCCCCC | 44.71 | UniProtKB CARBOHYD |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EDEM3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EDEM3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EDEM3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-195, AND MASSSPECTROMETRY. |